Clinical Trial Update: Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata [NA]

View source ↗

Summary

Pilot study evaluating the safety and efficacy of apremilast in adults with moderate to severe Alopecia Areata has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Alopecia Areata | NA | Status: COMPLETED | Results posted: 2023-11-07